Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates
2018 ◽
Vol 105
(3)
◽
pp. 719-729
◽
2012 ◽
Vol 52
(S1)
◽
2018 ◽
2019 ◽
Vol 8
(9)
◽
pp. 664-675
◽
2020 ◽
Vol 41
(6)
◽
pp. 248-267
◽
2019 ◽
Vol 59
(6)
◽
pp. 880-889
◽